Hypericin--the facts about a controversial agent
- PMID: 15638760
- DOI: 10.2174/1381612053382287
Hypericin--the facts about a controversial agent
Abstract
Hypericin is a naturally occurring substance found in the common St. John's Wort (Hypericum species) and can also be synthesized from the anthraquinone derivative emodin. As the main component of Hypericum perforatum, it has traditionally been used throughout the history of folk medicine. In the last three decades, hypericin has also become the subject of intensive biochemical research and is proving to be a multifunctional agent in drug and medicinal applications. Recent studies report antidepressive, antineoplastic, antitumor and antiviral (human immunodeficiency and hepatitis C virus) activities of hypericin; intriguing information even if confirmation of data is incomplete and mechanisms of these activities still remain largely unexplained. In other contemporary studies, screening hypericin for inhibitory effects on various pharmaceutically important enzymes such as MAO (monoaminoxidase), PKC (protein kinase C), dopamine-beta-hydroxylase, reverse transcriptase, telomerase and CYP (cytochrome P450), has yielded results supporting therapeutic potential. Research of hypericin and its effect on GABA-activated (gamma amino butyric acid) currents and NMDA (N-methyl-D-aspartat) receptors also indicate the therapeutic potential of this substance whereby new insights in stroke research (apoplexy) are expected. Also in the relatively newly established fields of medical photochemistry and photobiology, intensive research reveals hypericin to be a promising novel therapeutic and diagnostic agent in treatment and detection of cancer (photodynamic activation of free radical production). Hypericin is not new to the research community, but it is achieving a new and promising status as an effective agent in medical diagnostic and therapeutic applications. New, although controversial data, over the recent years dictate further research, re-evaluation and discussion of this substance. Our up-to-date summary of hypericin, its activities and potentials, is aimed to contribute to this process.
Similar articles
-
Cellular mechanisms and prospective applications of hypericin in photodynamic therapy.Curr Med Chem. 2006;13(18):2189-204. doi: 10.2174/092986706777935267. Curr Med Chem. 2006. PMID: 16918348 Review.
-
Catalytic inhibition of human DNA topoisomerase IIalpha by hypericin, a naphthodianthrone from St. John's wort (Hypericum perforatum).Biochem Pharmacol. 2001 Oct 15;62(8):1059-70. doi: 10.1016/s0006-2952(01)00759-6. Biochem Pharmacol. 2001. PMID: 11597574
-
Hypericin in cancer treatment: more light on the way.Int J Biochem Cell Biol. 2002 Mar;34(3):221-41. doi: 10.1016/s1357-2725(01)00126-1. Int J Biochem Cell Biol. 2002. PMID: 11849990 Review.
-
[Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].Ceska Slov Farm. 2007 Apr;56(2):62-6. Ceska Slov Farm. 2007. PMID: 17619301 Review. Czech.
-
St John's Wort (Hypericum perforatum L.) photomedicine: hypericin-photodynamic therapy induces metastatic melanoma cell death.PLoS One. 2014 Jul 30;9(7):e103762. doi: 10.1371/journal.pone.0103762. eCollection 2014. PLoS One. 2014. PMID: 25076130 Free PMC article.
Cited by
-
Hypericin as a potential drug for treating Alzheimer's disease and type 2 diabetes with a view to drug repositioning.CNS Neurosci Ther. 2023 Nov;29(11):3307-3321. doi: 10.1111/cns.14260. Epub 2023 May 14. CNS Neurosci Ther. 2023. PMID: 37183545 Free PMC article.
-
Case Report: Psychiatric Symptoms Associated With the Moderna mRNA COVID-19 Vaccine Administration and Their Resolution.Clin Med Insights Case Rep. 2023 Apr 12;16:11795476231166626. doi: 10.1177/11795476231166626. eCollection 2023. Clin Med Insights Case Rep. 2023. PMID: 37065637 Free PMC article.
-
Alternative Oxidase Gene Family in Hypericum perforatum L.: Characterization and Expression at the Post-germinative Phase.Front Plant Sci. 2016 Aug 11;7:1043. doi: 10.3389/fpls.2016.01043. eCollection 2016. Front Plant Sci. 2016. PMID: 27563303 Free PMC article.
-
Unveiling disulfidptosis-related biomarkers and predicting drugs in Alzheimer's disease.Sci Rep. 2024 Aug 30;14(1):20185. doi: 10.1038/s41598-024-70893-7. Sci Rep. 2024. PMID: 39215110 Free PMC article.
-
Highly efficient green synthesis and photodynamic therapeutic study of hypericin and its derivatives.RSC Adv. 2018 Jun 13;8(39):21786-21792. doi: 10.1039/c8ra03732a. eCollection 2018 Jun 13. RSC Adv. 2018. PMID: 35541722 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials